[Rd] NY Times article

Frank E Harrell Jr f.harrell at vanderbilt.edu
Sun Jan 11 16:21:23 CET 2009

Nicholas please note that FDA does not require type III sums of squares, 
LOCF, and the use of any particular software.  It is just the fact that 
FDA does not disallow type III tests and LOCF that prevents pharma from 
abandoning these terrible methods.

Frank E Harrell Jr   Professor and Chair           School of Medicine
                      Department of Biostatistics   Vanderbilt University

More information about the R-devel mailing list